The Indian government is currently reviewing customs duty concessions applicable to 118 products set to expire. This review involves input ...

Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...

New identity reinforces the company’s focus on innovation, customer partnerships and pharmaceutical drug containment and delivery solutions

Prime Minister Narendra Modi chaired the 54th PRAGATI meeting to evaluate infrastructure projects worth over Rs 16,000 crore. The meeting f...

Over 44,000 cans of Great Value Fruit Cocktail are recalled due to potential lead contamination concerns. The recall, initiated by Pacific ...

Ohio OH-7 Election 2026: Ohio’s 7th Congressional District has become unexpectedly competitive as Republican Max Miller faces domestic abus...

Maharashtra FDA has taken action against five warehouses for selling expired food products worth over Rs 48 lakh. Inspections revealed seri...

Nirmala Sitharaman expressed optimism regarding the speedy conclusion of the India-US trade agreement during her recent interaction. She hi...

Germany's Neovii Biotech and India's VINS Bioproducts will explore collaboration on manufacturing and commercialising immunoglobulin produc...

Bayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...

Sridhar Vembu responded to Elon Musk's claims regarding regulatory obstacles for Starlink in India. Vembu highlighted India's competitive e...

For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...

Linux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...

How India's largest ePharmacy is building an in-house quick-commerce engine across cities and why moving medicines in under an hour is far ...

There are times when a watchlist is more important than a buy list. But if you still insist on putting money in the market, look at fundame...

"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...

India aims to become drug-free by 2029 with a detailed three-year roadmap. This plan focuses on enforcement, synthetic drugs, demand reduct...